Active Pharmaceutical Ingredients Market Size 2020

Success! Thanks for contacting us. We will contact you soon

Active Pharmaceutical Ingredients Market Size 2020, Share, Growth, Trends, Drivers, Restraints, Opportunities, and Global Industry Analysis 2027

Published Date : Jul 2020

Category : Semiconductor & Electronics

Report Id : ReportCrux 044

Publisher Name : ReportCrux

Price : $2999

No of Pages : 215

Active Pharmaceutical Ingredients Market Size

The Active Pharmaceutical Ingredients Market is estimated to grow from USD 173.7 Billion in 2019 to reach USD 285.3 Billion by 2027, at a CAGR of 6.4% during the forecast period from 2020-2027.

Importance of generics, rising prevalence of chronic diseases, and increasing adoption of biopharmaceuticals are some of the major factors boosting the growth of active pharmaceutical ingredients market. Besides, hospital-acquired infections and rising prevalence of infectious diseases are also likely to drive the growth of the market over the forecast period.

Final Report will have an in-depth analysis of the COVID-19 impact on the Active Pharmaceuticals Ingredient Market

Active Pharmaceutical Ingredients Market by API Type (Chemical API, and Biological API); by Drug Type (Innovative Drugs, Generic Prescription, and Over-the-Counter (OTC) Drugs); by Manufacturer (Captive (In-House) Manufacturer, and Merchant (Contract) Manufacturer); by Application (Anti-Diabetic Drugs, Non-Steroidal Anti-Inflammatory Drugs, Cardiovascular Drugs, Musculoskeletal Drugs, Neurology Drugs, Oncology Drugs, and Others); and by Region: Global Industry Trends, Dynamics, Competitive Insights and Forecast Analysis, 2020 – 2027.

Market Drivers, Restraining, Opportunities

What are the Key Drivers responsible for the growth of Active Pharmaceutical Ingredients Market?

• Growing Adoption of Artificial Intelligence-Based Tools for Drug Discovery

• Increasing Uptake of Biopharmaceuticals

• Increasing Incidence of Chronic Diseases

• Growing Importance of Generics

• Growing Investments in Real-World Evidence By Pharmaceutical Companies

• Adoption of Organ-On-Chip Models in Drug Development

• Growing Focus on Precision Medicine

What are the restraints for the Active Pharmaceutical Ingredients Market growth?

• Increasing Penetration of Counterfeit Drugs

• Unfavorable Drug Price Control Policies Across Various Countries

What are the Opportunities in Active Pharmaceutical Ingredients Market?

• Potent Active Pharmaceutical Ingredients

• Emerging Biosimilars Market

Active Pharmaceutical Ingredient Manufacturers

Here are the 12 best Active Pharmaceutical Ingredient companies

Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Novartis AG
AbbVie Inc.
Pfizer, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
AstraZeneca Plc

Market Overview

The market report covers a basic overview of the market from the industry perspective. This will help the reader to get a gist about different industry dimensions from a manufacturer’s view. The report divides the market into different sections and is comprised of market revenue (value) by segments.

The report provides market data from 2016 till 2027, wherein, 2016 to 2018 will be historic years, 2019 would be the base year and 2020 to 2027 will be forecast years. The report provides different statistics and figures and charts that will help analyze trends and global active pharmaceutical ingredients market share along with its growth rate in different regions and countries.

Key players across the globe are profiled in the report along with its company landscaping. Product portfolio for each company, recent developments and company strategies are covered along with the company financials.

Economy Trends & Strategic Analysis

Various drivers, restraints and opportunities in the active pharmaceutical ingredients market are analyzed in detail in the report. Key drivers that make the overall market grow are discussed thoroughly, along with its impact on the sales of different products. Report also features restraining factors that are likely to restrain the market growth. As well, different opportunities which will propel the market in future and bring new growth avenues for major market players are discussed in detail. This will help in understanding the overall dynamics prevailing in the historic as well as in coming years.

Apart from this, the report covers various collaborations, mergers and acquisitions, regional expansions, new product launches and drug pipelines for the key players involved in the market.

Segmental and Geographic Analysis

The report describes in detail market segmentation by dividing the market based on its API type, drug type, manufacturer, application, and region and is analyzed from 2016 to 2027 by value and volume. All the segments are evaluated by taking into consideration the historic and future trends. All the segments with the dominating & fastest growing sub-segments and the factors responsible for the same are studied and are mentioned in the report.

Evident quantitative as well as qualitative insights about the segments are covered in the report along with forecast analysis of all the segments that expected to alter the market in the future are described in detail. The segmental analysis also highlights details about different aspects that will influence the market.

Based on the API type, the global market for active pharmaceutical ingredients is segmented into biological, and chemical API. On the basis of drug type, the market is categorized into innovative drugs, generic prescription, and over-the-counter (OTC) drugs. Based on manufacturer, the market is categorized into captive (in-house) manufacturer, and merchant (contract) manufacturer. On the basis of application, the market is categorized into anti-diabetic drugs, non-steroidal anti-inflammatory drugs, cardiovascular drugs, musculoskeletal drugs, neurology drugs, oncology drugs, and others. Trend analysis for all the segments is provided in detail in the report.

Market is divided regionally and by country level into North America (U.S., Canada, & Rest of North America), Europe (U.K., Germany, France, Italy, Spain, Russia & Rest of Europe), Asia Pacific (China, Japan, India, Australia, Southeast Asia, & Rest of Asia Pacific), Latin America (Brazil, Mexico, & Rest of Latin America) and Middle East and Africa (Saudi Arabia, South Africa, UAE, & Rest of Middle East and Africa).

The report gives the pursuer the complete idea and understanding of the market and the regional and country level value and volume scenario and essentials for the industry. Current market insights on the regional level are studied and centered while market estimation, thus giving the reader a specialized idea & plans, financial as well as recent market advancements globally.

Active Pharmaceutical Ingredients Market Scope

Attribute	Details
Market Size in 2019	USD 173.7 Billion
Market Size in 2027	USD 285.3 Billion
CAGR (%)	6.4% from 2020 to 2027
Historic Period	2017 - 2018
Base Year	2019
Forecast Period	2020-2027
Segments Covered	API Type, Drug Type, Manufacturer, Application, Region
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Active Pharmaceutical Ingredients Market Segmentation

By API Type

• Chemical API

• Biological API

By Drug Type

• Innovative Drugs

• Generic Prescription

• Over-the-Counter (OTC) Drugs

By Manufacturer

• Captive (In-House) Manufacturer

• Merchant (Contract) Manufacturer

By Application

• Oncology Drugs

• Non-Steroidal Anti-Inflammatory Drugs

• Cardiovascular Drugs

• Anti-Diabetic Drugs

• Neurology Drugs

• Musculoskeletal Drugs

• Others

By Region

• North America

-U.S.

-Canada

-Rest of North America

• Europe

-UK

-Germany

-France

-Italy

-Spain

-Russia

-Rest of Europe

• Asia Pacific

-China

-Japan

-India

-Australia

-Southeast Asia

-Rest of Asia Pacific

• Latin America

-Brazil

-Mexico

-Rest of Latin America

• Middle East and Africa

-Saudi Arabia

-South Africa

-UAE

-Rest of Middle East and Africa

Are you Looking for Regional Insights / Report Customization?

Europe Active Pharmaceutical Ingredients Market Size, Share and Analysis - 2027 | Request For Customized Sample Report

North America Active Pharmaceutical Ingredients Market Share, Size, and Industry Analysis 2027 | Request For Customized Sample Report

Asia-Pacific Active Pharmaceutical Ingredients Market Share, Size, and Industry Analysis 2027 | Request For Customized Sample Report

1. Preface

1.1. Report Description and Scope

1.2. Research Scope

2. Research Methodology

2.1. Research Methodology

2.1.1. Market Research Process

2.1.2. Primary Research

2.1.3. Secondary Research

2.2. Models

2.2.1. Company Share Analysis Model

2.2.2. Revenue Based Model

2.3. Research limitations

3. Executive Summary

3.1. Global Market Overview and Executive Summary 2016 - 2027 (USD Billion)

3.2. Market Snapshot

4. Market Dynamics and Industry Analysis

4.1. Global Active Pharmaceutical Ingredients Market: Introduction

4.2. Market Drivers

4.2.1. Growing Adoption of Artificial Intelligence-Based Tools for Drug Discovery

4.2.2. Increasing Uptake of Biopharmaceuticals

4.2.3. Increasing Incidence of Chronic Diseases

4.2.4. Growing Importance of Generics

4.2.5. Growing Investments in Real-World Evidence By Pharmaceutical Companies

4.2.6. Adoption of Organ-On-Chip Models in Drug Development

4.2.7. Growing Focus on Precision Medicine

4.3. Market Restraint

4.3.1. Increasing Penetration of Counterfeit Drugs

4.3.2. Unfavorable Drug Price Control Policies Across Various Countries

4.4. Market Opportunity

4.4.1. Potent Active Pharmaceutical Ingredients

4.4.2. Emerging Biosimilars Market

4.5. Porter’s Five Forces Analysis

5. Trending Insights on Current Market Scenario

5.1. Current Market Trends

5.2. SWOT Analysis

5.3. PESTEL Analysis

6. Market Growth Attractiveness Analysis

6.1. Growth Attractiveness Analysis, by API Type

6.2. Growth Attractiveness Analysis, by Drug Type

6.3. Growth Attractiveness Analysis, by Manufacturer

6.4. Growth Attractiveness Analysis, by Application

6.5. Growth Attractiveness Analysis, by Region

7. Competitive Share Analysis

7.1. Company Share Analysis

7.1.1. Global Active Pharmaceutical Ingredients Market: Company Market Share, 2019

7.2. Strategic Developments

7.2.1. Mergers and Acquisitions

7.2.2. New Drug Type Launches

7.2.3. Partnerships, Collaborations and Joint Ventures

8. Global Active Pharmaceutical Ingredients Market: API Type Segment Analysis

8.1. Introduction

8.1.1. Market Revenue Share, by API Type, 2019 & 2027

8.1.2. API Type Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.3. Chemical API

8.1.3.1. Chemical API Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.4. Biological API

8.1.4.1. Biological API Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9. Global Active Pharmaceutical Ingredients Market: Drug Type Segment Analysis

9.1. Introduction

9.1.1. Market Revenue Share, by Drug Type, 2019 & 2027

9.1.2. Drug Type Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.3. Innovative Drugs

9.1.3.1. Innovative Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.4. Generic Prescription

9.1.4.1. Generic Prescription Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.5. Over-the-Counter (OTC) Drugs

9.1.5.1. Over-the-Counter (OTC) Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10. Global Active Pharmaceutical Ingredients Market: Manufacturer Segment Analysis

10.1. Introduction

10.1.1. Market Revenue Share, by Manufacturer, 2019 & 2027

10.1.2. Manufacturer Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10.1.3. Captive (In-House) Manufacturer

10.1.3.1. Captive (In-House) Manufacturer Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10.1.4. Merchant (Contract) Manufacturer

10.1.4.1. Merchant (Contract) Manufacturer Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11. Global Active Pharmaceutical Ingredients Market: Application Segment Analysis

11.1. Introduction

11.1.1. Market Revenue Share, by Application, 2019 & 2027

11.1.2. Application Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.3. Oncology Drugs

11.1.3.1. Oncology Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.4. Non-Steroidal Anti-Inflammatory Drugs

11.1.4.1. Non-Steroidal Anti-Inflammatory Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.5. Cardiovascular Drugs

11.1.5.1. Cardiovascular Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.6. Anti-Diabetic Drugs

11.1.6.1. Anti-Diabetic Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.7. Neurology Drugs

11.1.7.1. Neurology Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.8. Musculoskeletal Drugs

11.1.8.1. Musculoskeletal Drugs Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.1.9. Others

11.1.9.1. Others Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

12. Global Active Pharmaceutical Ingredients Market: Regional Analysis

12.1. Regional Overview

12.1.1. Market Revenue Share, by Region, 2019 & 2027

12.1.2. Market Revenue Estimates and Forecast, by Region, 2016 - 2027 (USD Billion)

12.2. North America

12.2.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

12.2.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

12.2.3. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.2.4. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.2.5. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.2.6. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.2.7. U.S.

12.2.7.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.2.7.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.2.7.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.2.7.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.2.8. Canada

12.2.8.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.2.8.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.2.8.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.2.8.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.2.9. Rest of North America

12.2.9.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.2.9.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.2.9.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.2.9.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3. Europe

12.3.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

12.3.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

12.3.3. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.4. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.5. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.6. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.7. Germany

12.3.7.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.7.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.7.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.7.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.8. U.K.

12.3.8.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.8.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.8.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.8.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.9. France

12.3.9.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.9.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.9.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.9.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.10. Italy

12.3.10.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.10.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.10.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.10.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.11. Spain

12.3.11.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.11.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.11.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.11.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.12. Russia

12.3.12.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.12.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.12.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.12.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.3.13. Rest of Europe

12.3.13.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.3.13.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.3.13.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.3.13.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4. Asia Pacific

12.4.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

12.4.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

12.4.3. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.4. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.5. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.6. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4.7. China

12.4.7.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.7.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.7.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.7.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4.8. Japan

12.4.8.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.8.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.8.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.8.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4.9. India

12.4.9.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.9.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.9.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.9.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4.10. Australia

12.4.10.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.10.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.10.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.10.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4.11. Southeast Asia

12.4.11.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.11.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.11.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.11.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.4.12. Rest of Asia Pacific

12.4.12.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.4.12.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.4.12.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.4.12.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.5. Latin America

12.5.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

12.5.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

12.5.3. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.5.4. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.5.5. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.5.6. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.5.7. Brazil

12.5.7.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.5.7.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.5.7.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.5.7.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.5.8. Mexico

12.5.8.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.5.8.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.5.8.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.5.8.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.5.9. Rest of Latin America

12.5.9.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.5.9.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.5.9.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.5.9.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.6. Middle East and Africa

12.6.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

12.6.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

12.6.3. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.6.4. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.6.5. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.6.6. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.6.7. Saudi Arabia

12.6.7.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.6.7.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.6.7.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.6.7.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.6.8. South Africa

12.6.8.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.6.8.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.6.8.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.6.8.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.6.9. UAE

12.6.9.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.6.9.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.6.9.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.6.9.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

12.6.10. Rest of Middle East and Africa

12.6.10.1. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

12.6.10.2. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

12.6.10.3. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

12.6.10.4. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

13. Company Profiles

13.1. Bristol-Myers Squibb (U.S.)

13.1.1. Company Overview

13.1.2. Financial Overview

13.1.3. Product Portfolio

13.1.4. Business Strategy

13.1.5. Recent Developments

13.2. Sanofi (France)

13.2.1. Company Overview

13.2.2. Financial Overview

13.2.3. Product Portfolio

13.2.4. Business Strategy

13.2.5. Recent Developments

13.3. Boehringer Ingelheim (Germany)

13.3.1. Company Overview

13.3.2. Financial Overview

13.3.3. Product Portfolio

13.3.4. Business Strategy

13.3.5. Recent Developments

13.4. Novartis AG (Switzerland)

13.4.1. Company Overview

13.4.2. Financial Overview

13.4.3. Product Portfolio

13.4.4. Business Strategy

13.4.5. Recent Developments

13.5. AbbVie Inc. (U.S.)

13.5.1. Company Overview

13.5.2. Financial Overview

13.5.3. Product Portfolio

13.5.4. Business Strategy

13.5.5. Recent Developments

13.6. Pfizer, Inc. (U.S.)

13.6.1. Company Overview

13.6.2. Financial Overview

13.6.3. Product Portfolio

13.6.4. Business Strategy

13.6.5. Recent Developments

13.7. GlaxoSmithKline Plc (U.K.)

13.7.1. Company Overview

13.7.2. Financial Overview

13.7.3. Product Portfolio

13.7.4. Business Strategy

13.7.5. Recent Developments

13.8. Merck & Co., Inc. (U.S.)

13.8.1. Company Overview

13.8.2. Financial Overview

13.8.3. Product Portfolio

13.8.4. Business Strategy

13.8.5. Recent Developments

13.9. F. Hoffmann-La Roche Ltd. (Switzerland)

13.9.1. Company Overview

13.9.2. Financial Overview

13.9.3. Product Portfolio

13.9.4. Business Strategy

13.9.5. Recent Developments

13.10. Teva Pharmaceutical Industries Ltd. (Israel)

13.10.1. Company Overview

13.10.2. Financial Overview

13.10.3. Product Portfolio

13.10.4. Business Strategy

13.10.5. Recent Developments

13.11. Eli Lilly and Company (U.S.)

13.11.1. Company Overview

13.11.2. Financial Overview

13.11.3. Product Portfolio

13.11.4. Business Strategy

13.11.5. Recent Developments

13.12. AstraZeneca Plc (U.K.)

13.12.1. Company Overview

13.12.2. Financial Overview

13.12.3. Product Portfolio

13.12.4. Business Strategy

13.12.5. Recent Developments

14. Market Effect Factor Analysis

15. Report Conclusion

List of Figures

1. Global Active Pharmaceutical Ingredients Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

2. Porter’s Five Forces Analysis

3. SWOT Analysis

4. PESTEL Analysis

5. Company Share Analysis, 2019

6. Market Revenue Share Analysis, by API Type, 2019 & 2027

7. Market Revenue Estimates and Forecast, by Chemical API, 2016 - 2027 (USD Billion)

8. Market Revenue Estimates and Forecast, by Biological API, 2016 - 2027 (USD Billion)

9. Market Revenue Share Analysis, by Drug Type, 2019 & 2027

10. Market Revenue Estimates and Forecast, by Innovative Drugs, 2016 - 2027 (USD Billion)

11. Market Revenue Estimates and Forecast, by Generic Prescription, 2016 - 2027 (USD Billion)

12. Market Revenue Estimates and Forecast, by Over-the-Counter (OTC) Drugs, 2016 - 2027 (USD Billion)

13. Market Revenue Share Analysis, by Manufacturer, 2019 & 2027

14. Market Revenue Estimates and Forecast, by Captive (In-House) Manufacturer, 2016 - 2027 (USD Billion)

15. Market Revenue Estimates and Forecast, by Merchant (Contract) Manufacturer, 2016 - 2027 (USD Billion)

16. Market Revenue Share Analysis, by Application, 2019 & 2027

17. Market Revenue Estimates and Forecast, by Oncology Drugs, 2016 - 2027 (USD Billion)

18. Market Revenue Estimates and Forecast, by Non-Steroidal Anti-Inflammatory Drugs, 2016 - 2027 (USD Billion)

19. Market Revenue Estimates and Forecast, by Cardiovascular Drugs, 2016 - 2027 (USD Billion)

20. Market Revenue Estimates and Forecast, by Anti-Diabetic Drugs, 2016 - 2027 (USD Billion)

21. Market Revenue Estimates and Forecast, by Neurology Drugs, 2016 - 2027 (USD Billion)

22. Market Revenue Estimates and Forecast, by Musculoskeletal Drugs, 2016 - 2027 (USD Billion)

23. Market Revenue Estimates and Forecast, by Others, 2016 - 2027 (USD Billion)

24. Market Revenue Share Analysis, by Region, 2019 & 2027

25. North America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

26. Europe Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

27. Asia Pacific Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

28. Latin America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

29. Middle East and Africa Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

List of Tables

1. Global Active Pharmaceutical Ingredients Market: Snapshot

2. Market Growth Drivers: Impact Analysis

3. Market Restraints: Impact Analysis

4. Market Revenue Estimates and Forecast, by Region, 2016 - 2027 (USD Billion)

5. Market Revenue Estimates and Forecast, by API Type, 2016 - 2027 (USD Billion)

6. Market Revenue Estimates and Forecast, by Drug Type, 2016 - 2027 (USD Billion)

7. Market Revenue Estimates and Forecast, by Manufacturer, 2016 - 2027 (USD Billion)

8. Market Revenue Estimates and Forecast, by Application, 2016 - 2027 (USD Billion)

9. North America Market Size, by Country, 2016 - 2027 (USD Billion)

10. North America Market Size, by API Type, 2016 - 2027 (USD Billion)

11. North America Market Size, by Drug Type, 2016 - 2027 (USD Billion)

12. North America Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

13. North America Market Size, by Application, 2016 - 2027 (USD Billion)

14. U.S. Market Size, by API Type, 2016 - 2027 (USD Billion)

15. U.S. Market Size, by Drug Type, 2016 - 2027 (USD Billion)

16. U.S. Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

17. U.S. Market Size, by Application, 2016 - 2027 (USD Billion)

18. Canada Market Size, by API Type, 2016 - 2027 (USD Billion)

19. Canada Market Size, by Drug Type, 2016 - 2027 (USD Billion)

20. Canada Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

21. Canada Market Size, by Application, 2016 - 2027 (USD Billion)

22. Rest of North America Market Size, by API Type, 2016 - 2027 (USD Billion)

23. Rest of North America Market Size, by Drug Type, 2016 - 2027 (USD Billion)

24. Rest of North America Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

25. Rest of North America Market Size, by Application, 2016 - 2027 (USD Billion)

26. Europe Market Size, by Country, 2016 - 2027 (USD Billion)

27. Europe Market Size, by API Type, 2016 - 2027 (USD Billion)

28. Europe Market Size, by Drug Type, 2016 - 2027 (USD Billion)

29. Europe Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

30. Europe Market Size, by Application, 2016 - 2027 (USD Billion)

31. Germany Market Size, by API Type, 2016 - 2027 (USD Billion)

32. Germany Market Size, by Drug Type, 2016 - 2027 (USD Billion)

33. Germany Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

34. Germany Market Size, by Application, 2016 - 2027 (USD Billion)

35. U.K. Market Size, by API Type, 2016 - 2027 (USD Billion)

36. U.K. Market Size, by Drug Type, 2016 - 2027 (USD Billion)

37. U.K. Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

38. U.K. Market Size, by Application, 2016 - 2027 (USD Billion)

39. France Market Size, by API Type, 2016 - 2027 (USD Billion)

40. France Market Size, by Drug Type, 2016 - 2027 (USD Billion)

41. France Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

42. France Market Size, by Application, 2016 - 2027 (USD Billion)

43. Italy Market Size, by API Type, 2016 - 2027 (USD Billion)

44. Italy Market Size, by Drug Type, 2016 - 2027 (USD Billion)

45. Italy Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

46. Italy Market Size, by Application, 2016 - 2027 (USD Billion)

47. Spain Market Size, by API Type, 2016 - 2027 (USD Billion)

48. Spain Market Size, by Drug Type, 2016 - 2027 (USD Billion)

49. Spain Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

50. Spain Market Size, by Application, 2016 - 2027 (USD Billion)

51. Russia Market Size, by API Type, 2016 - 2027 (USD Billion)

52. Russia Market Size, by Drug Type, 2016 - 2027 (USD Billion)

53. Russia Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

54. Russia Market Size, by Application, 2016 - 2027 (USD Billion)

55. Rest of Europe Market Size, by API Type, 2016 - 2027 (USD Billion)

56. Rest of Europe Market Size, by Drug Type, 2016 - 2027 (USD Billion)

57. Rest of Europe Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

58. Rest of Europe Market Size, by Application, 2016 - 2027 (USD Billion)

59. Asia Pacific Market Size, by Country, 2016 - 2027 (USD Billion)

60. Asia Pacific Market Size, by API Type, 2016 - 2027 (USD Billion)

61. Asia Pacific Market Size, by Drug Type, 2016 - 2027 (USD Billion)

62. Asia Pacific Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

63. Asia Pacific Market Size, by Application, 2016 - 2027 (USD Billion)

64. China Market Size, by API Type, 2016 - 2027 (USD Billion)

65. China Market Size, by Drug Type, 2016 - 2027 (USD Billion)

66. China Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

67. China Market Size, by Application, 2016 - 2027 (USD Billion)

68. Japan Market Size, by API Type, 2016 - 2027 (USD Billion)

69. Japan Market Size, by Drug Type, 2016 - 2027 (USD Billion)

70. Japan Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

71. Japan Market Size, by Application, 2016 - 2027 (USD Billion)

72. India Market Size, by API Type, 2016 - 2027 (USD Billion)

73. India Market Size, by Drug Type, 2016 - 2027 (USD Billion)

74. India Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

75. India Market Size, by Application, 2016 - 2027 (USD Billion)

76. Australia Market Size, by API Type, 2016 - 2027 (USD Billion)

77. Australia Market Size, by Drug Type, 2016 - 2027 (USD Billion)

78. Australia Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

79. Australia Market Size, by Application, 2016 - 2027 (USD Billion)

80. Southeast Asia Market Size, by API Type, 2016 - 2027 (USD Billion)

81. Southeast Asia Market Size, by Drug Type, 2016 - 2027 (USD Billion)

82. Southeast Asia Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

83. Southeast Asia Market Size, by Application, 2016 - 2027 (USD Billion)

84. Rest of Asia Pacific Market Size, by API Type, 2016 - 2027 (USD Billion)

85. Rest of Asia Pacific Market Size, by Drug Type, 2016 - 2027 (USD Billion)

86. Rest of Asia Pacific Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

87. Rest of Asia Pacific Market Size, by Application, 2016 - 2027 (USD Billion)

88. Latin America Market Size, by Country, 2016 - 2027 (USD Billion)

89. Latin America Market Size, by API Type, 2016 - 2027 (USD Billion)

90. Latin America Market Size, by Drug Type, 2016 - 2027 (USD Billion)

91. Latin America Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

92. Latin America Market Size, by Application, 2016 - 2027 (USD Billion)

93. Brazil Market Size, by API Type, 2016 - 2027 (USD Billion)

94. Brazil Market Size, by Drug Type, 2016 - 2027 (USD Billion)

95. Brazil Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

96. Brazil Market Size, by Application, 2016 - 2027 (USD Billion)

97. Mexico Market Size, by API Type, 2016 - 2027 (USD Billion)

98. Mexico Market Size, by Drug Type, 2016 - 2027 (USD Billion)

99. Mexico Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

100. Mexico Market Size, by Application, 2016 - 2027 (USD Billion)

101. Rest of Latin America Market Size, by API Type, 2016 - 2027 (USD Billion)

102. Rest of Latin America Market Size, by Drug Type, 2016 - 2027 (USD Billion)

103. Rest of Latin America Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

104. Rest of Latin America Market Size, by Application, 2016 - 2027 (USD Billion)

105. Middle East and Africa Market Size, by Country, 2016 - 2027 (USD Billion)

106. Middle East and Africa Market Size, by API Type, 2016 - 2027 (USD Billion)

107. Middle East and Africa Market Size, by Drug Type, 2016 - 2027 (USD Billion)

108. Middle East and Africa Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

109. Middle East and Africa Market Size, by Application, 2016 - 2027 (USD Billion)

110. Saudi Arabia Market Size, by API Type, 2016 - 2027 (USD Billion)

111. Saudi Arabia Market Size, by Drug Type, 2016 - 2027 (USD Billion)

112. Saudi Arabia Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

113. Saudi Arabia Market Size, by Application, 2016 - 2027 (USD Billion)

114. South Africa Market Size, by API Type, 2016 - 2027 (USD Billion)

115. South Africa Market Size, by Drug Type, 2016 - 2027 (USD Billion)

116. South Africa Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

117. South Africa Market Size, by Application, 2016 - 2027 (USD Billion)

118. UAE Market Size, by API Type, 2016 - 2027 (USD Billion)

119. UAE Market Size, by Drug Type, 2016 - 2027 (USD Billion)

120. UAE Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

121. UAE Market Size, by Application, 2016 - 2027 (USD Billion)

122. Rest of Middle East and Africa Market Size, by API Type, 2016 - 2027 (USD Billion)

123. Rest of Middle East and Africa Market Size, by Drug Type, 2016 - 2027 (USD Billion)

124. Rest of Middle East and Africa Market Size, by Manufacturer, 2016 - 2027 (USD Billion)

125. Rest of Middle East and Africa Market Size, by Application, 2016 - 2027 (USD Billion)

Choose License Type

Single User $2999

Multi User $3999

Enterprise User $4999

Datapack User $1999

Active Pharmaceutical Ingredients Market Size 2020, Share, Growth, Trends, Drivers, Restraints, Opportunities, and Global Industry Analysis 2027

Published Date : Jul 2020

Category : Semiconductor & Electronics

Report Id : ReportCrux 044

Publisher Name : ReportCrux

Price : $2999

No of Pages : 215

Active Pharmaceutical Ingredients Market Size

Market Drivers, Restraining, Opportunities

Active Pharmaceutical Ingredient Manufacturers

Market Overview

Economy Trends & Strategic Analysis

Segmental and Geographic Analysis

Active Pharmaceutical Ingredients Market Scope

Active Pharmaceutical Ingredients Market Segmentation

Table of Contents

List of Figures

List of Tables

Choose License Type

TRUST ONLINE

GET IN TOUCH

Connect with us

Active Pharmaceutical Ingredients Market Size 2020, Share, Growth, Trends, Drivers, Restraints, Opportunities, and Global Industry Analysis 2027

Published Date : Jul 2020

Category : Semiconductor & Electronics

Report Id : ReportCrux 044

Publisher Name : ReportCrux

Price : $2999

No of Pages : 215

Active Pharmaceutical Ingredients Market Size

Market Drivers, Restraining, Opportunities

Active Pharmaceutical Ingredient Manufacturers

Market Overview

Economy Trends & Strategic Analysis

Segmental and Geographic Analysis

Active Pharmaceutical Ingredients Market Scope

Active Pharmaceutical Ingredients Market Segmentation

Table of Contents

List of Figures

List of Tables

Choose License Type

Related Reports

GET IN TOUCH

Connect with us